Japanese Phase I Study of AZD2014 in Advanced Solid Malignancies

Study identifier:D2270C00008

ClinicalTrials.gov identifier:NCT02398747

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AZD2014 Administered to Japanese Patients with Advanced Solid Malignancies

Medical condition

Advanced solid malignancies

Phase

Phase 1

Healthy volunteers

No

Study drug

AZD2014

Sex

All

Actual Enrollment

28

Study type

Interventional

Age

20 Years - 80 Years

Date

Study Start Date: 17 Mar 2015
Primary Completion Date: 12 Apr 2024
Study Completion Date: 12 Apr 2024

Study design

Allocation: Non-randomized
Endpoint Classification: Safety
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria